Mark Fishman
CIK: 0001786003
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BEAM
Beam Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
About Fishman Mark
Fishman Mark (SEC CIK 0001786003) files insider reports with the SEC as Director of Beam Therapeutics Inc. (BEAM).
Signal8 holds 2 ownership filings by Fishman Mark, all Form 4s, filed between Jun 6, 2025 and Jun 5, 2026. Those filings report 2 transactions, from Jun 4, 2025 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Fishman Mark's filings is in CAMBRIDGE, MA.
Recent filings by Fishman Mark
Other insiders filing for Beam Therapeutics Inc. (BEAM)
- Evans John M., CEO
- Cavanagh Bethany J, SVP, Finance and Treasurer
- Ciaramella Giuseppe, President
- Simon Amy, Chief Medical Officer
- FMR LLC, 10% Owner
- Shaw Christi, Director